Caplin Point Laboratories has informed that it enclosed Press Release regarding grant of USFDA approval for Abbreviated New Drug Application (ANDA) Thiamine Hydrochloride Injection USP, to its Subsidiary Caplin Steriles.
The above information is a part of company’s filings submitted to BSE.